562 related articles for article (PubMed ID: 9208130)
41. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
Liebmann C; Bossé R; Escher E
Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
[TBL] [Abstract][Full Text] [Related]
42. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.
Marceau F; Levesque L; Drapeau G; Rioux F; Salvino JM; Wolfe HR; Seoane PR; Sawutz DG
J Pharmacol Exp Ther; 1994 Jun; 269(3):1136-43. PubMed ID: 8014858
[TBL] [Abstract][Full Text] [Related]
43. Characterization of kinin receptors in human cultured detrusor smooth muscle cells.
Bellucci F; Cucchi P; Santicioli P; Lazzeri M; Turini D; Meini S
Br J Pharmacol; 2007 Jan; 150(2):192-9. PubMed ID: 17179953
[TBL] [Abstract][Full Text] [Related]
44. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
45. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
46. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
Smith JA; Webb C; Holford J; Burgess GM
Mol Pharmacol; 1995 Mar; 47(3):525-34. PubMed ID: 7700250
[TBL] [Abstract][Full Text] [Related]
47. Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor.
Saha JK; Sengupta JN; Goyal RK
J Pharmacol Exp Ther; 1991 Oct; 259(1):265-73. PubMed ID: 1656023
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Ile,Ser-bradykinin-induced changes in short-circuit current across rat colon.
Tien XY; Wallace LJ; Kachur JF; Won-Kim S; Gaginella TS
J Pharmacol Exp Ther; 1990 Sep; 254(3):1063-7. PubMed ID: 1697621
[TBL] [Abstract][Full Text] [Related]
49. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
50. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
51. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
[TBL] [Abstract][Full Text] [Related]
52. Bradykinin-induced accumulation of [3H]inositol-1-phosphate in human embryonic pituitary tumour cells by activation of a B2-receptor.
Sharif NA; Hunter JC; Hill RG; Hughes J
Neurosci Lett; 1988 Apr; 86(3):279-83. PubMed ID: 2898111
[TBL] [Abstract][Full Text] [Related]
53. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.
Srinivasan D; Kosaka AH; Daniels DV; Ford AP; Bhattacharya A
Eur J Pharmacol; 2004 Nov; 504(3):155-67. PubMed ID: 15541417
[TBL] [Abstract][Full Text] [Related]
55. Central involvement of kinin B1 and B2 receptors in the febrile response induced by endotoxin in rats.
Coelho MM; Oliveira CR; Pajolla GP; Calixto JB; Pelá IR
Br J Pharmacol; 1997 May; 121(2):296-302. PubMed ID: 9154340
[TBL] [Abstract][Full Text] [Related]
56. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects.
Morbidelli L; Parenti A; Giovannelli L; Granger HJ; Ledda F; Ziche M
Br J Pharmacol; 1998 Jul; 124(6):1286-92. PubMed ID: 9720802
[TBL] [Abstract][Full Text] [Related]
57. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
[TBL] [Abstract][Full Text] [Related]
58. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
Cabrini DA; Calixto JB
Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells.
Yang CM; Luo SF; Hsia HC
Br J Pharmacol; 1995 Jan; 114(1):67-72. PubMed ID: 7712031
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor.
Bromée T; Kukkonen JP; Andersson P; Conlon JM; Larhammar D
Br J Pharmacol; 2005 Jan; 144(1):11-6. PubMed ID: 15644864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
